The role of chronic hyperviscosity in vascular disease

Gregory Sloop1, Ralph E Holsworth2, Joseph J Weidman3

  • 1Department of Pathology, Benefis Hospitals, Great Falls, MT 59405, USA bigdaddypathologist@myway.com.

Insights

Blood viscosity plays a critical role in cardiovascular diseases like atherosclerosis and hypertension. Improving blood viscosity through methods such as therapeutic phlebotomy can reduce blood pressure and glucose levels.

Area of Science:

  • Cardiovascular Pathophysiology
  • Hematology
  • Metabolic Disorders

Background:

  • The pathogenesis of major cardiovascular diseases is incompletely understood, with the role of blood viscosity often overlooked.
  • Low-density lipoprotein (LDL) increases blood viscosity, promoting atherosclerosis and thrombosis.
  • High-density lipoprotein (HDL) decreases blood viscosity, offering protection against atherosclerosis.

Purpose of the Study:

  • To elucidate the overlooked role of blood viscosity in the pathogenesis of atherosclerosis, hypertension, and metabolic syndrome.
  • To investigate the mechanisms by which LDL and HDL influence blood viscosity and cardiovascular health.
  • To explore the therapeutic potential of modulating blood viscosity for managing cardiovascular and metabolic diseases.

Main Methods:

  • Review of existing literature on blood rheology and cardiovascular disease.
  • Analysis of the proposed mechanisms linking blood viscosity to atherosclerosis, hypertension, and metabolic syndrome.
  • Examination of the effects of therapeutic phlebotomy on blood pressure and glucose levels.

Main Results:

  • Blood viscosity significantly contributes to atherosclerosis by increasing it in low-flow areas, predisposing to thrombosis.
  • Atherosclerotic plaques are proposed to be organized mural thrombi.
  • Increased blood viscosity contributes to hypertension via elevated systemic vascular resistance.
  • Hyperviscosity reduces skeletal muscle perfusion and glucose utilization, leading to hyperglycemia in metabolic syndrome.

Conclusions:

  • Blood viscosity is a crucial, yet often overlooked, factor in the pathogenesis of major cardiovascular and metabolic diseases.
  • Therapeutic phlebotomy demonstrates potential in managing hypertension and hyperglycemia by improving blood viscosity.
  • Further research into blood viscosity modulation could offer novel therapeutic strategies for cardiovascular and metabolic health.

Related Concept Videos

Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
13.8K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
806
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Veins as Blood Reservoirs01:10

Veins as Blood Reservoirs

Veins, while chiefly responsible for circulating blood back to the heart, also function as storage vessels for blood. They house approximately 64 percent of the body's total blood volume, a feat made possible by their high capacitance—the inherent ability to expand and accommodate large volumes of blood, even under low pressure. The large diameter and thin walls of veins augment their distensibility, significantly more so than arteries, due to their classification as capacitance...
7.7K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
26
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
23